Apium Graveolens and Rosmarinus Officinalis Protect from Liver Toxicity Induced by Sodium Valproate in Rats and Potentiate its Anticonvulsant Activity on Pentylenetetrazol-Treated Rats by Hamza, Alaaeldin Ahmed et al.
 International Journal of Sciences: 
Basic and Applied Research 
(IJSBAR) 
 
ISSN 2307-4531 
(Print & Online) 
 
http://gssrr.org/index.php?journal=JournalOfBasicAndApplied 
--------------------------------------------------------------------------------------------------------------------------- 
163 
 
Apium Graveolens and Rosmarinus Officinalis Protect from 
Liver Toxicity Induced by Sodium Valproate in Rats and 
Potentiate its Anticonvulsant Activity on 
Pentylenetetrazol-Treated Rats 
Alaaeldin Ahmed Hamzaa, Fawkyeia EL hodairyb*, Hanan Mohamed Elwyc 
aHormone Evaluation Department, National Organization for Drug Control and Research (NODCAR), Giza, 
Egypt, NODCAR, 6 Abu Hazem St., Pyramids, Giza, Egyp, Tel. 20.01201991433- Fax:  +20.2.33933897 
bPhysiology Department,  NODCAR, Giza, Egypt 
cnalytical Chemistry Departments, NODCAR, Giza, Egypt 
aE-mail: alaa17mm@gmail.com 
 
Abstract 
Hepatic injury is a dose-limiting side effect of sodium valproate (VPA), a common used drug in the 
management of numerous nurological disorders, including epilepsy. The present study was designed to 
investigate the effect of Apium Grafionalies (AG) and Rosmarinus officinalis (RO) against VPA-induced liver 
injury. Hepatic toxicity was induced by the administration of VPA (500 mg/kg/day) once daily for a period of 7 
days. The hepatoprotective group received ethanolic extracts of AG and RO (200 mg/kg/day) for 7 days prior to 
VPA treatment for seven days. VPA liver toxicity was evaluated based on serum alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) activities and, albumin, and total protein levels as well as by 
histology. Serum ALT and AST activities were elevated and albumin and total protein levels were depleted. 
Histopathological changes in liver such as fatty degeneration and focal necrosis were associated with significant 
increase in TUNEL-positive cells and P53 protein in immunohistochemical study indicating the presence of 
DNA fragmentation.  
 
 
------------------------------------------------------------------------ 
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This biochemical and histological changes were associated with increased oxidative stress damage as evidenced 
by increases in protein carbonyl (P.Carbonyl) and decreases in total antioxidant capacity (TAC) in liver. These 
biochemical and histological disturbances were effectively attenuated on pretreatment with either AG or RO 
extract, which normalized P.Carbonyl and TAC and attenuated histopathological changes induced by VPA. 
These observations shed light on the hepatoprotective actions of both AG and RO extracts against experimental 
VPA toxicity. AG was characterized for its apigenin content while RO was characterized for its rosmarinic acid 
and carnazol contents. Besides, in a pentylenetetrazole (PTZ) rat clonic convulsion model, pretreatment with 
AG and RO (200 mg/kg) before VPA protected against PTZ-induced convulsion, where it delayed the onset of 
clonic convulsion in PTZ treated rats. 
Keywords: Sodium valproate; liver toxicity; protection; Apium gravuonalues; Rosmarinus officinalis; Liver 
toxicity;Sodium valproate;Apium Graveolens; Rosmarinus Officinalis; Anticonvulsant activity. 
1. Introduction 
Sodium valproate (VPA) is a branched-chain saturated fatty acid [2-propyl pentanoic acid] that is widely used 
for the treatment of epilepsy, and migraine headaches. VPA is being investigated as a novel histone deacetylase 
inhibitor in the treatment of certain forms of cancer [1]. Despite its effectiveness, VPA has been associated with 
hepatotoxic effects such as microvesicular steatosis, hepatocellular necrosis and  cholestatic liver injury in 
humans [2-4].  
VPA has been referred as the third most common xenobiotic suspected of causing death due to liver injury [5]. 
Moreover, acute and chronic animal models of VPA toxicity clearly show extensive microvesicular fatty 
changes, centriolubular degeneration, focal necrosis and infiltration of inflammatory cells in liver [6-8].  At the 
molecular level, growing body of evidence suggesting that excessive levels of free radicals are generated during 
VPA exposure, possibly as a consequence of VPA biotransformation by mitochondrial fatty acid â-oxidation 
and/or alterations in endogenous antioxidants [4, 9]. In rat studies, the depletions of endogenous antioxidant 
substances [10] and the elevations in oxidative stress markers [6,9-11] have been found to increase after acute 
and chronic VPA treatments. Conceivably, a big need arises to seek avenues that could alleviate VPA-induced 
hepatic injury. In fact, several compounds with antioxidant properties such as vitamin C, E, and U, carnitine 
omega-3, and safranal have been investigated in vitro and in vivo with some degree of success [7-9, 12-13]. 
In recent years, several natural extractions from plants have been shown to protect against chemical-induced 
liver toxicity. Conversely, no attempts have been made to reduce VPA liver complications and to boost its 
therapeutic efficacy by using the natural substances. Apium graveolens L. AG [celery, family: Umbelliferae] and 
Rosmarinus officinalis (RO) [Rosmary, family: Lamiaceae] are cultivated in Mediterranean area for their 
essential oils and are often used as popular aromatic herbs and spices due their characteristic smells. 
Phytochemical investigations of AG seeds revealed the presence of terpenes like limonene, flavonoids like 
apigenin and phthalide glycosides [14-16] RO was also found to contain several antioxidant compounds such as 
phenolic diterpenoids like carnosic acid, carnosol, rosmanol and epirosmanol [17-19] and carotenoids and alpa- 
tocopherol [20]. 
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AG seeds are traditionally used as a diuretic, tranquilizer, anti-spasmodic and anti-rheumatic [21]. AG seed 
extracts have been reported to possess a broad spectrum of pharmacological effects including anti-inflammatory 
[22], anti-cancer [14, 16, 23], anti-hepatotoxic [24-25], anti-hypercholesterolemia [26], anti-ulcer [27] and 
antioxidant [22,28].  Furthermore, we previously demonstrated that AG seeds can reverse a, VPA-induced 
reproductive toxicity in rats by ablating oxidative stress [29].  
RO is a native Mediterranean plant that has commonly been used against asthma, eczema and rheumatism [30]. 
RO extracts are found to exhibit different protective effects in rats such anti-hyperglycemic [31], anti-
ulcerogenic [32], hepatoprotective [33] antioxidant and anti-genotoxicity [34] and anticancer activity [35] and 
antidepressant behavior [36].  The extract of RO has been shown to have potent hepatoprotective effects against 
a variety of hepatotoxic chemical agents including tert-butyl hydroperoxide [37], carbon tetrachloride [30,38-
39] and azathioprine [40].   
This investigation was set to evaluate whether treatment with either AG or RO ethanol extract could reduce 
VPA-induced liver toxicity in male rats. To accomplish this, we monitored levels of hepatocellular oxidative 
stress and markers of hepatic function and histopathologic investigation. On the other hand, the possibility of 
pharmacologic synergy with VPA was explored in a pentylenetetrazole (PTZ) rat convulsion model.   
2. Materials and Methods 
2.1. Chemicals 
The dried plants, AG seeds, and RO leaves, were purchased from Experimental Plant Station in Faculty of 
Pharmacy, Cairo University, Giza, Cairo. Plants were collected during the flowering period in March and April 
2015. The plants growth environment is typically Mediterranean. The plants were authenticated by plant 
taxonomist; Dr. Nael M. Fawzi, compared to related specimens available at the herbarium of the Flora and 
Taxonomy Department, Agricultural Research Center, Giza, Egypt. VPA (Depakin®), it is one of products of 
Sanofi-Synthelabo Company, Paris, France. 2,4-dinitophenylhydrazine, thiobarbituric acid, reduced glutathione, 
5,5-dithiobis (2-nitrobenzoic acid), Folin's reagent, epinephrine, SOD enzyme, H2O2, and bovine albumin were 
obtained from Sigma Chemical Co. (St. Louis, MO). All other chemicals were obtained from common 
commercial suppliers.  
2.2. Experimental animals  
Adult male albino rats (150-200g) of the Wistar strain were obtained from the animal house, National 
Organization for Drug Control and Research (NODCAR). All procedures with animals were performed in 
accordance with the standard guidelines [41] and approved by local ethical committee of NODCAR. They were 
maintained on standard pellet diet and tap water ad libitum and were kept in polycarbonate cages with wood 
chip bedding under a 12 h. light/dark cycle and room temperature 22-24°C. Rats were acclimatized to the 
environment for two week prior to experimental use.  
2.3. Preparation of Plant Extract 
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To increase the yield of extraction in a shorter time and a lower temperature, the liquid-phase microwave-
assisted process was used for extraction of AG and ZO according to the methods described by (Pan and his 
colleagues 2001). These microwave-assisted extraction applications are based upon the selective heating of the 
matrix that contains the target extract when the matrix is immersed in a solvent transparent (ethanol and water) 
the microwaves. This solvent allows for selective heating of particular components within the matrix without 
using excessive heating. Hundreds grams of dried plants, AG seeds and RO leaves were mixed in 1000 ml of 
70% ethanol. Every 10 gm of ground herb mixed with 100 ml of 70% ethanol in 250-ml conical flask. The 
Mixtures were then irradiated with microwave for two minutes. The output power of the microwave oven is 300 
W. The suspensions were irradiated with 25 seconds of power on to give the desired temperature of about 80 °C 
and 5 second of power-on for heating and then 10 second of power-off for cooling. Then the extracts were 
finally filtered through gauze and evaporated under vacuum at 40°C using a rotary evaporator. The yields of AG 
and RO were about 16% and 10% respectively.  The dried extracts were dissolved in distilled water before 
administration.  
2.4. Standardizations of AG and RE by high-pressure liquid chromatography  
Both of AG and RE were standardized in reference to its major contents exploiting high-pressure liquid 
chromatography (HPLC) analysis. The separations were carried out on HPLC apparatus (Agilent 1100 series). 
The dry extract of both AG and RO was dissolved in mobile phase (30% acetonitrile at pH 3.0) and separations 
were performed on a 250 X 4.6mm i.d., 5 µm reverse-phase Hypersil BDS-C18 analytical column (Thermo 
Scientific, USA). The mobile phase was acetonitril (A) and acidified water containing 2.5% formic acid (B). 
The gradient was as follows: 0 min, 5% A; 10min, 15% A; 30 min, 25% A, 35 min, 30% A; 50 min, 55% A; 55 
min 90% A; 60 min, 100% A  and then hold for 10 min before returning to the initial conditions. The flow rate 
was 1.2 ml/min for AG and 1.0 ml/ min RO and the absorbance was monitored at 265.5 nm for AG and 280nm 
for RO according to the method described by [42]. 
2.5. Rat Liver Toxicity Studies 
2.5.1. Experimental Design 
VPA was dissolved in a saline solution and was administered to animal in a volume of one ml /100 g body 
weight. The control animals received an equivalent volume of saline based on body weight. The hepatotoxic 
dose of VPA (500 mg/kg b.wt.) used in the present study is based on the previous hepatotoxic study of VPA in 
rats [6]. The two extracts were given orally by gavage at the concentration 200 mg/Kg of body weight, which 
previously found to prevent liver toxicity induced in rats by other hepatotoxic agents [33]. The rats were 
randomly divided into six groups (eight rats each) and were treated daily for two weeks  as follow: the first 
control group was received daily an equivalent volume of water for 14 days, the VPA- treated group was treated 
with water for 14 days and was injected daily an intraperitoneal dose of VPA (500 mg/kg b.wt.) for 7 day after 7 
days of water treatment, the AG-treated group was treated orally with AG extract (200 mg/kg b.wt.) for 14 days, 
the RO-treated group was treated orally with RO extract (200 mg/kg b.wt.) for 14 days, AG plus VPA-treated 
group was pretreated orally with AG extracts daily for 7 days before VPA treatment for further 7 days, RO plus 
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VPA-treated group was pretreated orally with RO extracts daily for 7 days before VPA treatment for further 7 
days. After 24 hours of last treatment with each of VPA, herbal extracts or vehicle solution administration, 
blood and organ samples were obtained from the four groups under diethyl ether anesthesia.  
2.5.2. Sample Preparation 
Blood was collected from the retro-orbital plexus under diethyl ether anesthesia. Serum was separated by 
centrifugation in a refrigerated centrifuge (4°C) at 3000 rpm for 20 minutes. Fresh serum samples were used for 
the determination of albumin and total protein levels as well as enzyme activities of ALT and AST. After the 
collection of blood samples, all animals were sacrificed by decapitations under diethyl ether anesthesia and two 
liver samples were collected from each animal. The first part was removed and immediately immersed in 10% 
buffered formalin for histopathological examinations. The other part was homogenized in ice-cold Tris-HCL 
buffer (150 mM KCl, 50 mM Tris, pH 7.4) to give 10% homogenate w/v and stored at -20°C for further 
biochemical analyses. Aliquots were prepared and used for determination of different biochemical markers.  
2.5.3. Biochemical Assays 
2.5.3.1. Assessment of liver damage 
ALT and AST activities as well as Albumin and total protein concentrations were determined in serum using 
Randox reagent kits (Randox Laboratories Ltd., Co. Antrim, United Kingdom) and following their instruction 
manual 
2.5.3.2. Determination of Oxidative Stress Markers 
Malondialdehyde (MDA) level, an indirect index of lipid peroxidation (LP) [43] was measured in hepatic 
tissues.  The determination of MDA, as described in [44] is based on its reaction with thiobarbituric acid (TBA) 
to form a pink complex with absorption maximum at 535 nm. The level of MDA and was expressed was 
expressed as nmol of MDA/mg protein. 
P.carbonyl is vital marker of oxidative stress. It has some advantages in comparison with other markers because 
of relative early formation and stability of carbonylated proteins [45]. Hepatic P.carbonyl content was 
determined according to method of [46]. This method is based on spectrophotometric detection of the reaction 
of 2,4-dinitophenylhydrazine with P.carbonyl to form protein hydrazones at 370nm. The level P.carbonyl was 
expressed as nmol of carbonyl group per milligram of protein with molar extinction coefficient of 22000 M/cm. 
The total antioxidant capacity in liver was evaluated using ferric reducing antioxidant power (FRAP) assay. The 
FRAP assay was determined according to the method described by [47]. The FRAP assay measures the change 
in absorbance at 593 nm due to the formation of a blue colored ferrous- tripyridyltriazine complex from 
colorless oxidized ferric form by the action of electron donating antioxidants. The total protein content in liver 
was determined according to the Lowry's method modified by [48].   In all the estimations, absorbance was 
recorded using a PerkinElmer, Lambda 25 UV/VIS spectrophotometer.  
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2.5.4. Histopathological examination 
Pieces of liver were fixed in 10% neutral phosphate-buffer formalin and the hydrated tissue sections 5μm in 
thickness were stained with Hematoxylin and Eosin. The sections were examined under a Leica DMRB/E light 
microscope.  
2.5.5. TUNEL assay for DNA fragmentation and immunohistochemical assay for P53 
Terminal deoxynuclotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay detects single-strand 
DNA breaks and double strand DNA breaks, therefore TUNEL positively is seen in both necrosis and apoptosis 
[49]. Endogenous peroxidase was blocked by incubation in 1.3% H2O2 in PBS before enzymatic labeling. The 
fragmented DNA was end labeled with horseradish peroxidase (HRP) conjugated-biotinylated nucleotide at 30-
OH end using the terminal deoxynucleotidyl transferase recombinant enzyme according to the manufacturer’s 
instructions (Promega, Madison, Wisconsin, USA). Detection was carried out using H2O2 and 
diaminobenzidine (DAB) substrate.  Sections were counterstained with hematoxylin. In the normal section the 
nuclei stain blue and the positive TUNEL nuclei stained brown. 
P53 is a multi-function protein and known as the guardian of the genome [50, 51]. Elevation of P53 protein in 
response to DNA damage triggers either a transient cell cycle arrest or apoptosis [50, 51]. So that combination 
of TUNEL and P53 techniques should always be used to detect DNA damage and genotoxic stress. 
2.6. Rat Acute, Pentylenetetrazole (PTZ), anticonvulsant Studies 
PTZ-induced clonic seizures represent a routine test for screening anticonvulsants [52]. In the present work, the 
selection of PTZ dose to induce clonic convulsion n our animals and antiepileptic VPA dose was according to 
Safar and his colleagues [53].  Administration of PTZ (60 mg/kg i.p.) induced: freezing, myclonic twitches, 
clonic convulsion. The VPA group received the sub effective dose of VPA (100 mg/kg, IP) to study the 
possibility of pharmacologic synergy of AG and RO with VPA against PTZ-induced clonic convulsion. The 
animals were divided into six groups of analysis (eight rats each); group 1 received single intraperitoneal PTZ 
dose (60mg/kg ) to induce clonic convulsion [53]. Group 2 is the VPA group injected intraperitoneally with 
VPA (100mg /kg, ip) 30 min before PTZ administration. AG group received AG (200mg/kg) orally, 1 hour 
before PTZ treatment (60 mg/kg ). RO group received RO (200 mg/kg PO) 1 hour before PTZ administration 
(60 mg/kg IP). In AG+VPA group animals were received AG (200 mg/kg) 30 min before injection of VPA dose 
then convulsion was induced by injection PTZ after 30 min of VPA treatment. In RO+VPA group animals were 
received AG (200 mg/kg) 30 min before injection of VPA dose then convulsion was induced by injection PTZ 
after 30 min of VPA treatment. 
2.6.1. Seizures assessment  
After PTZ injection, rats were placed singly in Plexiglas cages and were observed for 30 min. Incidences and 
latency of clonic convulsive attacks, which lasts over 3 s with an accompanying loss of righting reflex were 
recorded. Seizure latency for rats showing no convulsive attacks within the observation period was taken as 30 
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min.  
2.7. Statistical Analysis 
The data are expressed as group mean ± SEM. The statistical analysis was carried out one-way analysis of 
variance (ANOVA), with SPSS version 20 statistical program (SPSS Inc., Chicago, IL, USA). ANOVA 
performed to detect differences between all various groups. When significant differences by ANOVA were 
detected analysis of a difference between the means of the treated and control groups were performed by using 
Dennett’s t test.  
3. Results  
3.1. Effect of AG and RO on VPA-induced liver damage  
Table 1 revealed that treatment with VPA alone caused a significant increase in serum ALT and AST activities 
and a significant decrease in serum albumin, and total protein levels compared to the control group. No 
significant differences were observed in the serum markers of liver damage in the animals treated with AG or 
RO. However the elevation in serum ALT and AST activity as well as the depletion in albumin and total protein 
levels was significantly attenuated in groups treated with AG + VPA or RO + VPA in comparison to VPA-
treated rats. This improvement was more pronounced in the group of rats pretreated with RO.   
Table 1: Effect of AG or RO on serum ALT, AST activity, and albumin and total protein concentrations in 
control and VPA treated rats 
Groups ALT (U/ml) AST (U/ml) Albumin (g/dl) Total protein (g/dl) 
Control 26.13 ± 0.65       118.25 ± 3.18       3.97 ± 0.13     7.04 ± 0.06 
AG 27.14 ± 0.81       119.80 ± 2.02  3.99 ± 0.14 7.04 ± 0.05 
RO 26.83 ± 0.20       117.62 ± 1.67  3.95 ± 0.15 6.99 ± 0.06 
VPA 47.51 ± 1.54a 163.50 ± 8.51a 3.13 ± 0.20a 5.06 ± 0.10a 
AG+VPA 28.08 ± 1.51b 133.12 ± 3.63b 3.29 ± 0.15 a, b 5.31 ± 0.05 a, b 
RO+VPA 28.08 ± 1.52b 119.02 ± 6.48b 3.41 ± 0.17 a, b 6.13 ± 0.23 a, b 
 
Data are represented as mean ± S.E.M. of eight independent rats of each group. a a<0.05 vs. control, b<0.05 vs. 
VPA.  
3.2. Effect of AG and RO on VPA-induced Histological Changes  
Histopathological examination of liver tissue was done to further illustrate VPA-induced liver damage (Figure 1 
& 2). Liver of rats in control showed normal histological structure of liver (Figure 1 a & 2 a). Extensive fatty 
degeneration of the hepatocytes, with focal necrosis, vacuolated cytoplasm was clearly seen in the VPA-treated 
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group (Figure 1 b & 2 b). In VPA intoxicated rats, the portal tract was  
 
Figure 1: Photomicrographs of liver sections in central area. (a) Liver section from control rats showing the 
normal arrangement of hepatocytes. Liver section of VPA-treated rats (b) showing extensive degeneration of 
hepatocytes with focal necrosis (thin arrows), vacuolated cytoplasm (thick arrows) and damaged central vein 
(CV). Group of rats pretreated with AP (c) or RO (d) before VPA exhibiting relatively normal appearance of 
hepatocytes with moderate degeneration and focal vacuolated cells (H & E, X 400). 
markedly infiltrated with mononuclear cells and showed severe dilated congested portal vessels (Figure 2 b) and 
some focal cells appeared small in size with deeply stained acidophilic cytoplasm and dark nuclei and other 
were with pale vacuolated cytoplasm. Animals treated with AG or RO showed normal liver morphology with 
slight degeneration and vacuolization of hepatocytes (Figure 1 c & 2 c). Rats treated AG + VPA or RO + VPA 
showed better preserved appearance of hepatocytes (Figure 1 d & 2 d) with a decrease in focal necrosis and 
inflammations. 
 
Figure 2: Photomicrographs of liver sections in portal area (p). (a) Liver section from control rats showing 
normal hepatic architecture. Liver section of VPA-treated rats (b) showing degeneration of hepatocytes with 
focal eosinohyilic cytoplasm and pyknotic nuclei (thin arrows), vacuolization (thick arrows) and inflammatory 
cell infiltration (asterisk). (c) Liver section of AG-pretreated rats before VPA showing some degree of swelling 
and degeneration in hepatocytes. (d) Liver section of rat pretreated with RO before VPA showing better-
preserved appearance of hepatocytes with some degree of degeneration and inflammation (H&E, X 400). 
3.3. Effect of AG and RO on VPA-induced oxidative stress in liver 
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The effects of different treatments on the oxidant–antioxidant status of the livers are depicted in Figure 3. VPA 
treatment alone produced a significant increase in hepatic MDA (Figure 3 A) and P.carbonyl contents (Figure 3 
B) with concomitant significant decrease in TAC (Figure 3 C) in liver when compared with the control group. 
The combined treatment with AG or RO plus VPA significantly decreased hepatic MDA and P.carbonyl 
contents and significantly increased hepatic TAC when compared with VPA-treated rats (Figure 3). 
Interestingly, rats received AG or RO alone did not show any changes in these oxidative stress markers.   
 
Figure 3: Effect of AG or RO on hepatic MDA (A) and P. Carbonyl  (B) contents and  TAC (FRAP assay) in 
control and VPA treated rats. Data are expressed as means ± SEM for eight animals in each group. a P < 0.05 
vs. control, b P < 0.05 vs VPA. 
3.4. Effect of AG and RO on VPA-induced DNA fragmentation and up regulation of P53 protein 
Immunohistochemical study showed that VPA groups revealed extensive positively brown expression of 
TUNEL and P53 protein in hepatocytes especially in centriolobular and periportal areas (Figure 4 & 5). AG + 
VPA treated and RO + VPA treated groups AG and RO attenuated the number of TUNEL and P53 positive cells 
comparing to VPA-treated group. 
 
Figure 4: Effect of medicinal herbs on VPA-induced DNA strand breaks were assessed by TUNEL assay. 
Photomicrographs of liver sections in central area. There are no TUNEL-positive cells in liver section of control 
rats (a), the nuclei stained blue with hematoxyline. Liver section of VPA-treated rats (b) showing extensive 
TUNEL- positive hepatocytes (arrows), the hepatocyte nuclei and cytosol stained brown.  Group of rats 
pretreated with AP (c) or RO (d) before VPA exhibiting nearly normal appearance of hepatocytes and there is a 
marked reduction in TUNEL-positive cells. Sections were counterstained with hematoxyline (X 400). 
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Figure 5: Effect of medicinal herbs on VPA-induced DNA damage was assessed by immunohistochemical 
localization of P53 protein. Photomicrographs of liver sections in central area. There are no P53-positive cells in 
liver section of control rats (a), the nuclei stained blue with hematoxyline. Liver section of VPA-treated rats (b) 
hepatocytes showing frequent P53 immunoreactivity (arrows). Group of rats pretreated with AP (c) or RO (d) 
before VPA showing a marked reduction in P53-positively-stained cells. (X 400). 
3.5. Effect of VPA  and  AG and RO on clonic convulsion (min) induced by PTZ  
Figure 6 depicts that rats subjected to PTZ exhibited clonic convulsions with 4.6 -min average seizure latency. 
This was manifested as bilateral forelimb myoclonus with rearing, or with loss of postural control.  Sub effective 
dose of VPA showed significant tendency to protect against onset of rat clonic convulsions with 8, 3- min 
average seizure latency but did not reduce the convulsions' incidence in rats. Each of AG and RO alone did not 
induce an increase in latency (onset) of rat clonic convulsions with 6 and 5.3- min average seizure latency, when 
compared with control PTZ value.  On the other hand, it was of current interest to seek possible synergy with 
anticonvulsant effects of VPA. AG and RO successfully delayed the seizure latency to reach 13 and 11.4 min 
respectively as compared to PTZ treated rats. 
 
Figure 6: Effect of VPA ,   AG and RO on PTZ-induced clonic convulsion (min). PTZ was injected 30 min 
after VPA administration. The combination groups received RO or AG  then VPA, respectively; at 30 min 
intervals, before PTZ was given. Data of clonic convulsion latency are expressed as means ± SEM for eight 
animals in each group. a P < 0.05 vs. PTZ control, b P < 0.05 vs VPA. 
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3.6. Standardizations of AG and RO by HPLC 
The HPLC profiles of AG and RO extracts were run in parallel to the corresponding standards under similar 
analytical conditions (Figure 7 & 8). The standard peak for apigenin was observed at retention time (15.117 
min.). While the running of extract resulted in a sharp peak at 15.156 min., which was found to be apigenin 
present in the extract with other peaks present in HPLC profile of AG. In the present study, apigenin content 
was about 32 µg/ 200 mg of AG extract.  
 The HPLC analysis of rosmarinic acid and carnosol of rosemary crud extract are shown in table 2. HPLC 
analysis of RO extract revealed the presence of some chromatographic peaks among which are rosmarinic acid 
at 17.654 min and carnosol at 50.246 min (Figure 8). HPLC quantitative analysis showed that rosmarinic acid 
content was 6.23 mg per 200mg RO crud extract while carnosol was 2.56 mg per 200 mg of RO crud extract.  
 
Figure 7: Chromatogram UV obtained at 265.5 nm of AG extract (a) run in parallel to the apigenin standard  (b) 
under similar analytical conditions. The standard peak for apigenin was observed at retention time (15.117 
min.). While the running of extract resulted in a sharp peak at 15.156 min., which was found to be apigenin 
present in the extract with other peaks present in HPLC profile of AG. 
 
Figure 8: Chromatogram UV obtained at 280 nm of RO extract (a) run in parallel to the rosmarinic acid and 
carnosol standards (b) under similar analytical conditions. The standard peak for rosmarinic acid (1) was 
observed at retention time (17.65 min.) and for carnosol was (2) observed at retention time (50.25 min.). 
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Table 2: Yield, antioxidant capacity and the qualitative–quantitative analyses of the ethanol extract from AG 
and RO carried out using an HPLC. 
Extract Yield Antioxidant 
FRAP assay TAC (mmol/g) 
Compound identified Content / 
200 mg extract 
AO 16.1%    0.61 ± 0.10 Apigenin 32 µg ± 0.02 
 
RO 
 
10.2% 
 
2.17  ±  0.10 
 
Rosmarinic acid 
 
6.23 mg ± 0.03 
   Carnosol 2.56 mg ± 0.03 
Values are means ± SME of three experiments. 
4. Discussion  
The present study demonstrates that treatment with AG and RO extracts significantly reduces the severity of 
VPA-induced liver dysfunction, cellular steatosis and histopathological changes in male albino rats. Likewise, it 
reveals that AG and RO enhance the anticonvulsant effects of VPA in a PTZ rat- convulsion model. 
In this report, VPA induced liver toxicity in male Wistar rats at dose level 500 mg/kg b.wt. for seven days, 
which is in agreement with previous experimental animal studies [6, 8, 54] VPA-mediated hepatic injury is 
characterized by with a dose-dependent rise in serum liver enzymes, decline in plasma albumin, microvesicular 
steatosis and necrosis [8, 9, 54]. In this study, VPA treatment caused a significant elevation in serum AST, and 
ALT activities, indicating the liver injury induced by VPA. Serum albumin and protein levels were decreased in 
rats treated with VPA, which was in consistent with that of previous reports [8,55-56]. This hepatotoxicity 
observed in VPA-treated rats was confirmed histopathological lesions and characterized by hepatocellular focal 
necrosis, fatty changes, and inflammatory cell infiltration. However, pretreatment of animals by either AG or 
RO attenuated the liver toxicity induced by VPA as shown by decreased ALT and AST activities and associated 
decrease of serum albumin and protein levels as well as low histopathological changes in comparison to the 
VPA-treated group. Similar hepatoprotective effects were obtained from AG and RO treated rats intoxication 
with paracetamol, thioacetamide [24], CCL4 [25, 33, 38-39],  di(2-ethylhexyl) phthalate [57] and creosote [58].  
Multiple pathways are implicated in the pathogenesis of VPA-induced liver damage. Overproduction of free 
radicals and decreased hepatic endogenous antioxidants has been considered as a corner stone in developing 
VPA-induced liver damage [9-10]. Oxidative stress in a cell is activates when the antioxidant defense system is 
overwhelmed by the production of ROS and free radicals [59]. In the present work, VPA-induced oxidative 
stress was confirmed by the elevation of oxidized lipids (MDA) and proteins (P. carbonyl) and as well as the 
depletion of TAC liver which were consistent with previous studies [8, 10]. Besides liver necrosis and oxidative 
damage, VPA intoxication significantly increased the number of TUNEL-positive cells, especially in damaged 
areas of liver. TUNEL assay may detected single-strand DNA breaks as well as double–strand DNA breaks, 
therefore, TUNEL positively is seen in both necrotic and apoptotic hepatocytes [49].  We have earlier 
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demonstrated, via increasing of Bax and caspase-3expressions, that apoptosis occurs in the rat liver after similar 
VPA treatments [9]. These findings concur with those of the previous studies, which reported that VPA induced 
DNA fragmentation and apoptosis in hepatocyte cell line [60-61], this TUNEL positively effect was 
accompanied by increased accumulation of P53 protein indicating the presence of DNA fragmentation. 
Furthermore, excessive amount of free radicals production has been related with an increase in DNA oxidative 
stress described in series of treatment with VPA epileptic patients [10]. In this study P53 protein accumulation 
could be a temporary response to DNA fragmentation, which allows the cells to repair its DNA damage or 
trigger apoptosis. P53 protein acting to induce cell-cycle arrest or apoptosis in response to cell stress or DNA 
damage, thereby to prevent replication of damaged DNA and to protect the integrity of the genome [51,62]. 
Therefore, over productions of free radicals and hence oxidative stress may account, at least in part, for hepatic 
injury associated with VPA treatment. AO and RO pretreatments were effective to decrease VPA -induced 
oxidative stress and DNA fragmentation (as indicated by TUNEL and P53 protein immunohistochemical 
techniques). In accordance with our findings, the previous results showed comparable protective effect of RO  
against oxidative DNA damage  induced by several by oxidative stress agents   [34, 63- 64].  
We used PTZ rat model of convulsion to preliminarily evaluate possible of potential anticonvulsant action of 
AG and RO. Our results demonstrated an anticonvulsant potential of AG and RO in the PTZ acute convulsion 
model in rats. These compounds significantly increased the anticonvulsant effect of VPA. The mechanism of 
their anticonvulsant action is not precisely known and could attribute to their antioxidant effects or might 
attributed to interaction with GABA. 
This protective effect could be the result of direct antioxidant properties found in both herbs, which was 
reinforced here (FRAP assay) and has been documented previously [17-18,  22, 30, 58]. It is well known that 
phenolic compounds, which are powerful antioxidants, found in both herbs could responsible for these 
antioxidant protective effects. The major active phenolic ingredients isolated from celery seeds like limonene, 
apigenin and phthalide glycosides [14-16] are known to have different pharmacological effects. Limonene and 
phthalides have been exhibited high activity to induce detoxifying enzyme glutathione S-transferase in the 
mouse liver [14]. In the same line, Phenolic diterpenes such as carnosic acid, carnosol, rosmanol and rosmanol 
[17- 18, 65] and carotenoid and alpa-tocopherol [20] have been documented as the principal antioxidant 
constituents of RO extracts. The efficacy of AG and RO may be attributed to the presence flavonoids apigenin 
as well as rosmarinic acid and carnosol as active constituents for AG and RO respectively. In the present study, 
apigenin content was about 32 µg/ 200 mg of AG extract while, rosmarinic acid and carnosol content were 
about 6.23 mg and 2.56 / 200 mg of RO extract, respectively. Comparable findings have been reported 
previously [65-67].  
Indeed, the protective effect of either AG or RO against VPA toxicity might be mediated not only by their 
potent antioxidant properties but through their detoxification capacity. Apigenin is an antioxidant and found to 
be the major component in AG [66]. However, it cannot be excluded that these plant extracts may inhibit several 
metabolic intermediates and ROS formed during the process of microsomal enzyme activation. Limonene and 
phthalides have been exhibited high activity to induce detoxifying enzyme glutathione S-transferase in the 
mouse liver [14]. Celery extract has been caused a significant decrease of cytochrome P450 in the liver of mice 
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[68]. AG extract also was found to prevent mucosal inflammation through its inhibitory effect on prostaglandin 
production [27]. Moreover, RO extract was reported to induce xenobiotic detoxification enzymes in rat liver 
[69]. The preventive action of RO can alternatively be mediated through the induction of detoxification enzymes 
[33]. However, RO was more effective than AG at preventing liver damage. Histological and AST changes were 
prevented to greater extent in rats pretreated with RO than in rats pretreated with AG. The high reducing 
capacity (FRAP assay) of RO extract observed here could contributed in its higher protective effect. 
5. Conclusion  
In conclusion, the result of the present study suggests an effective strategy to abate VPA-induced hepatic injury. 
Both of AG and RO act via antioxidant capacity of active phenolic compounds to restore liver function and 
integrity and to synergize with antiepileptic effects. 
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